/OSRH
OSRH Stock - OSR Holdings, Inc.
Healthcare|BiotechnologyNASDAQ
$0.65+13.65%
+$0.08 (+13.65%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.29
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.66
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.72
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OSRH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.64 – $0.66
TARGET (TP)$0.75
STOP LOSS$0.60
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.34
52W High$12.54
52W Low$0.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-3,524,549 | $-1,830,700 | $-35,388 | $-3,308 | $-23,812 |
| Net Income | $-2,410,879 | $403,780 | $-35,388 | $-3,308 | $-23,812 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.54 | $0.06 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
OSRHBeat Rate
100%
Last 1 quarters
Avg Surprise
+16.7%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$-0.10
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
+16.7%
$-0.10vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | $-0.12 | $-0.10 | +16.7% | ✓ BEAT |
Q3 2025 | Aug 14, 2025 | — | $0.02 | — | — |
Q2 2025 | May 20, 2025 | — | $-1.04 | — | — |
Q2 2025 | Apr 22, 2025 | — | $-0.16 | — | — |
Q4 2024 | Nov 15, 2024 | — | $-0.06 | — | — |
Q3 2024 | Aug 20, 2024 | — | $-0.02 | — | — |
Q2 2024 | May 16, 2024 | — | $-0.60 | — | — |
Q2 2024 | Apr 18, 2024 | — | $-0.02 | — | — |
Q4 2023 | Nov 8, 2023 | — | $0.01 | — | — |
Q3 2023 | Aug 15, 2023 | — | $0.03 | — | — |
Q2 2023 | May 23, 2023 | — | $0.01 | — | — |
Q2 2023 | Apr 1, 2023 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Latest News
OSR Holdings Announces Woori IO Shareholders Approve Proposed Acquisition By OSR
📈 PositiveBenzinga•Dec 19, 2025, 04:52 PM
OSR Holdings' Subsidiary Vaximm And BCM Europe Shorten Exclusivity Period From 6 Months To 3 Months For VXM01 Global Licensing Deal
📉 NegativeBenzinga•Dec 2, 2025, 03:00 PM
OSR Holdings shares are trading higher after its unit Vaximm entered a non-binding term sheet with BCM Europe to explore a potential exclusive global licensing agreement for its VXM01 oral cancer immunotherapy platform.
📈 PositiveBenzinga•Nov 21, 2025, 02:26 PM
OSR Holdings' Vaximm Enters Into Non-Binding Term Sheet With BCM Europe To Explore Potential Exclusive Global Licensing Agreement For VXM01, Oral Cancer Immunotherapy Platform
📈 PositiveBenzinga•Nov 21, 2025, 02:25 PM
OSR Holdings Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $627.747K Miss $761.000K Estimate
➖ NeutralBenzinga•Nov 12, 2025, 10:30 PM
OSR Holdings Announces Findings From Woori IO Pilot Study Showing Its Noninvasive Glucose Monitor Demonstrated Accuracy And Precision
📈 PositiveBenzinga•Nov 6, 2025, 01:36 PM
OSRH stock has given up its prior gain. OSR Holdings shares were trading higher after the company signed a definitive agreement to acquire noninvasive glucose monitoring company Woori IO.
➖ NeutralBenzinga•Oct 14, 2025, 05:11 PM
OSR Holdings shares are trading higher after the company signed a definitive agreement to acquire noninvasive glucose monitoring company Woori IO.
📈 PositiveBenzinga•Oct 14, 2025, 12:34 PM
Under Agreement, Woori IO Would Become Wholly Owned Subsidiary Of OSR Holdings And Woori IO Shareholders Will Receive Newly Issued Shares Valued At $10.5M
📈 PositiveBenzinga•Oct 14, 2025, 12:34 PM
OSR Holdings Signs Definitive Agreement To Acquire Noninvasive Glucose Monitoring Co., Woori IO
📈 PositiveBenzinga•Oct 14, 2025, 12:33 PM
OSR Holdings Receives Non-Compliance Letter From Nasdaq
📉 NegativeBenzinga•Sep 9, 2025, 09:38 PM
Frequently Asked Questions about OSRH
What is OSRH's current stock price?
OSR Holdings, Inc. (OSRH) is currently trading at $0.65 per share. The stock has moved +13.65% today.
What is the analyst price target for OSRH?
No analyst price targets are currently available for this stock.
What sector is OSR Holdings, Inc. in?
OSR Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is OSRH's market cap?
OSR Holdings, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does OSRH pay dividends?
No, OSR Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADAP
Adaptimmune Therapeutics plc
$0.05
Mkt Cap: $0.0B
ANL
Adlai Nortye Ltd.
$1.52
Mkt Cap: $0.0B
APLM
Apollomics, Inc.
$16.73
Mkt Cap: $0.0B
BLRX
BioLineRx Ltd.
$3.04
Mkt Cap: $0.0B
EDSA
Edesa Biotech, Inc.
$1.48
Mkt Cap: $0.0B
ERNA
Ernexa Therapeutics Inc.
$1.31
Mkt Cap: $0.0B
GOVX
GeoVax Labs, Inc.
$0.16
Mkt Cap: $0.0B
LPCN
Lipocine Inc.
$4.25
Mkt Cap: $0.0B
PMN
ProMIS Neurosciences, Inc.
$8.55
Mkt Cap: $0.0B
THAR
Tharimmune, Inc.
$2.32
Mkt Cap: $0.1B
Explore stocks similar to OSRH for comparison